Do you want to read an article? Please log in or register.
Costs of Workplace Productivity Loss in Patients with Connective Tissue Disease Associated Interstitial Lung Disease
Interstitial Lung Disease
RECOMMENDED
Related content
RECOMMENDED
Interstitial Lung Disease
Connective tissue disease-associated interstitial lung disease and outcomes after hospitalization: A cohort study
Respir Med.
Ratwani AP, Ahmad KI, Barnett SD, Nathan SD, Brown AW
doi: 10.1016/j.rmed.2019.05.020.
Interstitial Lung Disease
Telomere Length and Genetic Variant Associations with Interstitial Lung Disease Progression and Survival
Eur Respir J.
Newton CA, Oldham JM, Ley B, Anand V, Adegunsoye A, Liu G, Batra K, Torrealba J, Kozlitina J, Glazer C, Strek ME5, Wolters PJ, Noth I, Garcia CK
doi: 10.1183/13993003.
RECOMMENDED
Interstitial Lung Disease
The Spectrum of Interstitial Lung Disease Associated with Autoimmune Diseases: Data of a 3.6-Year Prospective Study from a Referral Center of Interstitial Lung Disease and Lung Transplantation
★ 2
Recommended by
Dr Martin Frey, Faculty Member
J Clin Med.
Atienza-Mateo B, Remuzgo-Martínez S, Mora Cuesta VM, Iturbe-Fernández D, Fernández-Rozas S, Prieto-Peña D, Calderón-Goercke M, Corrales A, Blanco Rodríguez GB, Gómez-Román JJ, González-Gay MÁ, Cifrián JM
doi: 10.3390/jcm9061606.
RECOMMENDED
Interstitial Lung Disease
Lung Ultrasound in the Screening of Pulmonary Interstitial Involvement Secondary to Systemic Connective Tissue Disease: A Prospective Pilot Study Involving 180 Patients
★ 2
Recommended by
Dr Martin Frey, Faculty Member
J Clin Med
Buda N, Wojteczek A, Masiak A, Piskunowicz M, Batko W, Zdrojewski Z
doi: 10.3390/jcm10184114
Further Publications
Corticosteroids are associated with reduced skeletal muscle function in interstitial lung disease patients with mild dyspnea
Respir Med.
Hanada M, Ishimatsu Y, Sakamoto N, Nagura H, Oikawa M, Morimoto Y, Sato S, Mukae H, Kozu R
doi: 10.1016/j.rmed.2020.106184.
RECOMMENDED
Interstitial Lung DiseasePulmonary FibrosisPneumonia
Differentiation of Idiopathic Pulmonary Fibrosis from Connective Tissue Disease-Related Interstitial Lung Disease Using Quantitative Imaging
★ 2
Recommended by
Dr Martin Frey, Faculty Member
★ 3
Recommended by
Dr Marcus Hesse, Faculty Member
J Clin Med
Chung JH, Adegunsoye A, Cannon B, Vij R, Oldham JM, King C, Montner SM, Thirkateh P, Barnett S, Karwoski R, Bartholmai BJ, Strek M, Nathan SD
doi: 10.3390/jcm10122663
RECOMMENDED
Interstitial Lung Disease
Clinical and Functional Characteristics of Patients with Unclassifiable Interstitial Lung Disease (uILD): Long-Term Follow-Up Data from European IPF Registry (eurIPFreg)
★ 2
Recommended by
Dr Martin Frey, Faculty Member
J Clin Med.
Krauss E, El-Guelai M, Pons-Kuehnemann J, Dartsch RC, Tello S, Korfei M, Mahavadi P, Breithecker A, Fink L, Stoehr M, Majeed RW, Seeger W, Crestani B, Guenther A
doi: 10.3390/jcm9082499.
RECOMMENDED
Interstitial Lung Disease
Safety and tolerability of nintedanib in patients with systemic sclerosis-associated interstitial lung disease: data from the SENSCIS trial
★ 2
Recommended by
Dr Martin Frey, Faculty Member
Ann Rheum Dis.
Seibold JR, Maher TM, Highland KB, Assassi S, Azuma A, Hummers LK, Costabel U, von Wangenheim U, Kohlbrenner V, Gahlemann M, Alves M, Distler O, SENSCIS trial investigators
doi: 10.1136/annrheumdis-2020-217331.
RECOMMENDED
Interstitial Lung DiseasePulmonary Fibrosis
Nintedanib in patients with progressive fibrosing interstitial lung diseases-subgroup analyses by interstitial lung disease diagnosis in the INBUILD trial: a randomised, double-blind, placebo-controlled, parallel-group trial
★ 3
Recommended by
Dr Martin Frey, Faculty Member
★ 3
Recommended by
Dr Marcus Hesse, Faculty Member
Lancet Respir Med.
Wells AU, Flaherty KR, Brown KK, Inoue Y, Devaraj A, Richeldi L, Moua T, Crestani B, Wuyts WA, Stowasser S, Quaresma M, Goeldner RG, Schlenker-Herceg R, Kolb M, INBUILD trial investigators.
doi: 10.1016/S2213-2600(20)30036-9.